CONSUN PHARMA(01681),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01681 CONSUN PHARMA

Closed 05-21 16:08:15

14.470

+0.070

+0.49%

High14.530	Low14.260	Vol2.23M
Open14.400	D1 Closing14.400	Amplitude1.88%
Mkt Cap12.17B	Tradable Cap12.17B	Total Shares841.00M
T/O32.13M	T/O Rate0.27%	Tradable Shares841.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01681","market":"HK","secType":"STK","nameCN":"CONSUN PHARMA","latestPrice":14.47,"timestamp":1779350895004,"preClose":14.4,"halted":0,"volume":2232000,"delay":0,"changeRate":0.004861111111111131,"floatShares":841000000,"shares":841000000,"eps":1.26,"marketStatus":"Closed","change":0.07,"latestTime":"05-21 16:08:15","open":14.4,"high":14.53,"low":14.26,"amount":32130255,"amplitude":0.01875,"askPrice":14.47,"askSize":16000,"bidPrice":14.44,"bidSize":50000,"shortable":3,"etf":0,"ttmEps":1.402141,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1779413400000},"marketStatusCode":5,"adr":0,"listingDate":1387382400000,"exchange":"SEHK","adjPreClose":14.4,"dividendRate":0.052247,"openAndCloseTimeList":[[1779327000000,1779336000000],[1779339600000,1779350400000]],"volumeRatio":0.978612,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01681","defaultTab":"news","newsList":[{"id":"2636451988","title":"Consun Pharmaceutical files HKEX disclosure return, repurchases shares at HKD 14.42 each","url":"https://stock-news.laohu8.com/highlight/detail?id=2636451988","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636451988?lang=en_us&edition=fundamental","pubTime":"2026-05-20 18:29","pubTimestamp":1779272966,"startTime":"0","endTime":"0","summary":"Consun Pharmaceutical repurchased 50,000 shares on May 20 for holding as treasury shares.Buyback price range HKD 14.39 to HKD 14.45 per share; aggregate consideration HKD 721,010.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Consun Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on May 20, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDLc6fqD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","01681","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633198583","title":"Concerns Surrounding Consun Pharmaceutical Group's (HKG:1681) Performance","url":"https://stock-news.laohu8.com/highlight/detail?id=2633198583","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633198583?lang=en_us&edition=fundamental","pubTime":"2026-05-07 07:00","pubTimestamp":1778108434,"startTime":"0","endTime":"0","summary":"Consun Pharmaceutical Group Limited's ( HKG:1681 ) healthy profit numbers didn't contain any surprises for investors...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1681/consun-pharmaceutical-group-shares/news/concerns-surrounding-consun-pharmaceutical-groups-hkg1681-pe","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1681/consun-pharmaceutical-group-shares/news/concerns-surrounding-consun-pharmaceutical-groups-hkg1681-pe","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1606","01681","BK4211","FCF","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182868940","title":"Consun Pharma Maintains 841.55 Million Issued Shares in April; Public Float Remains Compliant","url":"https://stock-news.laohu8.com/highlight/detail?id=1182868940","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182868940?lang=en_us&edition=fundamental","pubTime":"2026-05-04 17:06","pubTimestamp":1777885615,"startTime":"0","endTime":"0","summary":"Consun Pharmaceutical Group Limited reported no changes in its share structure for the month ended 30 April 2026, according to the company’s latest monthly return filed with the Hong Kong Stock...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124178866","title":"CONSUN PHARMA (01681) Undergoing Valuation Rerating as It Builds Leading \"Nephrology Flagship\" Competitive Edge","url":"https://stock-news.laohu8.com/highlight/detail?id=1124178866","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124178866?lang=en_us&edition=fundamental","pubTime":"2026-05-03 17:33","pubTimestamp":1777800796,"startTime":"0","endTime":"0","summary":"On April 21, CONSUN PHARMA (01681) held a celebration event for its inclusion in the Hong Kong Stock Connect and an investor exchange meeting in Shenzhen. During the event, Chairman and President An...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","01681","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630372445","title":"Consun Pharmaceutical publishes 2025 ESG report","url":"https://stock-news.laohu8.com/highlight/detail?id=2630372445","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630372445?lang=en_us&edition=fundamental","pubTime":"2026-04-28 17:56","pubTimestamp":1777370190,"startTime":"0","endTime":"0","summary":"Consun Pharmaceutical released its 2025 ESG report, outlining governance changes that embed ESG targets into medium- and long-term planning.Board expanded climate oversight via a Climate Change Governance Manual aligned with SEHK climate disclosure guidance and IFRS S2.Pipeline update showed 25 R&D projects at year-end 2025, including 12% classified as first-in-class at Phase III or registration review stage.Compliance program delivered 39 compliance training sessions in 2025, covering 1,606 employees.Quality controls reported 19 external supervisory inspections and internal audit flight inspections in 2025, with 100% pass rate.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Consun Pharmaceutical Group Ltd. published the original conte","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL3k6cPN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1606","01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128838848","title":"CONSUN PHARMA’s 2025 ESG Report: Lower Emissions, Strong R&D Pipeline and RMB 14.76 Billion Brand Valuation","url":"https://stock-news.laohu8.com/highlight/detail?id=1128838848","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128838848?lang=en_us&edition=fundamental","pubTime":"2026-04-28 17:47","pubTimestamp":1777369672,"startTime":"0","endTime":"0","summary":"CONSUN PHARMACEUTICAL GROUP (CONSUN PHARMA) has published its 10th Environmental, Social and Governance (ESG) Report, covering the 2025 financial year and approved by the board on 26 March 2026....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146874780","title":"康臣藥業2025年度業績速覽：收入增長15.2%至34.17億元，腎科板塊領跑業務","url":"https://stock-news.laohu8.com/highlight/detail?id=1146874780","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146874780?lang=en_us&edition=fundamental","pubTime":"2026-04-28 17:31","pubTimestamp":1777368693,"startTime":"0","endTime":"0","summary":"康臣藥業集團有限公司（「康臣藥業」，股份代號：01681）公佈其截至2025年12月31日止年度的綜合業績，顯示整體營運保持穩健增長。期內，公司收入約為34.17億元人民幣（以下幣種均為人民幣），同比上升15.2%。全年的利潤總額（含非控股股東權益）約為10.89億元，同比增長18.7%；其中股東應佔利潤約為10.78億元，同比上升18.4%。 一、業務概覽及分部表現   •...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康臣藥業2025年度業績速覽：收入增長15.2%至34.17億元，腎科板塊領跑業務","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150149794","title":"Consun Pharma Schedules 26 May 2026 AGM, Proposes HKD0.40 Final Dividend and New Share Mandates","url":"https://stock-news.laohu8.com/highlight/detail?id=1150149794","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150149794?lang=en_us&edition=fundamental","pubTime":"2026-04-28 06:44","pubTimestamp":1777329865,"startTime":"0","endTime":"0","summary":"Consun Pharmaceutical Group Limited (“Consun Pharma”) has issued a circular convening its 2026 annual general meeting (AGM) for 26 May 2026 at 10:00 a.m., to be held both physically in Hong Kong and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131808333","title":"ConSun Pharma Calls 26 May 2026 Hybrid AGM to Approve FY 2025 Results, HKD0.40 Final Dividend and New Share Mandates","url":"https://stock-news.laohu8.com/highlight/detail?id=1131808333","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131808333?lang=en_us&edition=fundamental","pubTime":"2026-04-28 06:44","pubTimestamp":1777329841,"startTime":"0","endTime":"0","summary":"ConSun Pharmaceutical Group Limited has issued a proxy form summarising resolutions to be tabled at its annual general meeting scheduled for 26 May 2026 at 10:00 a.m. The meeting will be held in a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630345281","title":"Consun Pharmaceutical announces annual general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2630345281","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630345281?lang=en_us&edition=fundamental","pubTime":"2026-04-28 06:40","pubTimestamp":1777329648,"startTime":"0","endTime":"0","summary":"Consun Pharmaceutical Group will hold its annual general meeting in Hong Kong on May 26, 2026.Shareholders will vote on adoption of audited consolidated financial statements for year ended Dec. 31, 2025.Resolutions include re-election of directors, authorization to set directors’ remuneration, and re-appointment of KPMG as auditor.Mandates will be sought to issue up to 20% of issued shares, repurchase up to 10%, and extend issuance capacity by shares repurchased.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Consun Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 27, 2026, and is solely responsible for ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDL44KrPv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1606","01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113630500","title":"Strong Fundamentals and Inclusion in Stock Connect Create Key Investment Window for Consun Pharma (01681)","url":"https://stock-news.laohu8.com/highlight/detail?id=1113630500","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113630500?lang=en_us&edition=fundamental","pubTime":"2026-04-07 19:36","pubTimestamp":1775561809,"startTime":"0","endTime":"0","summary":"Recent policy support has been favorable for both traditional Chinese medicine and innovative drugs this year. During the Two Sessions, the government work report emphasized \"advancing the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","01681","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195563694","title":"CONSUN PHARMA Adds 124,000 Shares in March Through Option Exercise; Public Float Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=1195563694","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195563694?lang=en_us&edition=fundamental","pubTime":"2026-04-02 12:24","pubTimestamp":1775103859,"startTime":"0","endTime":"0","summary":"Consun Pharmaceutical Group Limited’s monthly return for the period ended 31 March 2026 shows a net issuance of 124,000 ordinary shares, lifting the total outstanding share count to approximately...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622384552","title":"Consun Pharmaceutical Group (SEHK:1681) Earnings Growth And 31.5% Margins Challenge Valuation Skeptics","url":"https://stock-news.laohu8.com/highlight/detail?id=2622384552","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622384552?lang=en_us&edition=fundamental","pubTime":"2026-03-28 20:11","pubTimestamp":1774699865,"startTime":"0","endTime":"0","summary":"Consun Pharmaceutical Group (SEHK:1681) opened FY 2025 with first half revenue of C¥1.57b and basic EPS of C¥0.59, set against trailing twelve month revenue of C¥3.42b and EPS of C¥1.27 that reflect earnings growth of 18.4% over the past year. The company has seen revenue move from C¥2.97b to C¥3.42b on a trailing basis, while EPS has gone from C¥1.11 to C¥1.27, supported by a trailing net profit margin of 31.5% that edges above last year’s 30.7%. This keeps profitability squarely in focus...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1681/consun-pharmaceutical-group-shares/news/consun-pharmaceutical-group-sehk1681-earnings-growth-and-315","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1681/consun-pharmaceutical-group-shares/news/consun-pharmaceutical-group-sehk1681-earnings-growth-and-315","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1191","01681","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622005839","title":"BRIEF-Consun Pharmaceutical Logs FY Revenue RMB 3,420 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2622005839","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622005839?lang=en_us&edition=fundamental","pubTime":"2026-03-26 15:12","pubTimestamp":1774509120,"startTime":"0","endTime":"0","summary":"BRIEF-Consun Pharmaceutical Logs FY Revenue RMB 3,420 MlnMarch 26 (Reuters) - Consun Pharmaceutical Group Ltd 1681.HK:FY REVENUE RMB 3,420 MILLIONFINAL DIVIDEND OF HKD0.40 PER SHAREPROFIT ATTRIBUTABLE FOR YEAR RMB1.08 BILLIONFurther company coverage: 1681.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nPLX28844B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681","BK1191","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130311766","title":"Consun Pharma to Distribute Final Dividend of HK$0.4 Per Share on June 22","url":"https://stock-news.laohu8.com/highlight/detail?id=1130311766","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130311766?lang=en_us&edition=fundamental","pubTime":"2026-03-26 12:42","pubTimestamp":1774500131,"startTime":"0","endTime":"0","summary":"Consun Pharmaceutical Group announced that it will pay a final dividend of HK$0.4 per share on June 22, 2026.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","VIG","BK1191","BK4585","BK1606","01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143021140","title":"Consun Pharma Reports 18.41% Rise in Annual Profit Attributable to Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=1143021140","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143021140?lang=en_us&edition=fundamental","pubTime":"2026-03-26 12:11","pubTimestamp":1774498269,"startTime":"0","endTime":"0","summary":"Consun Pharmaceutical Group announced its annual results for the year ended December 31, 2025. The group recorded revenue of RMB 3.417 billion, an increase of 15.17% compared to the previous year....","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1606","01681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622880189","title":"Consun Pharmaceutical FY2025 final dividend proposed at HKD 0.4 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2622880189","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622880189?lang=en_us&edition=fundamental","pubTime":"2026-03-26 12:03","pubTimestamp":1774497838,"startTime":"0","endTime":"0","summary":"Shareholder approval is scheduled for May 26, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Consun Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 26, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL3GDpd4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01681","BK1191","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622880991","title":"Consun Pharmaceutical FY2025 profit attributable to equity shareholders climbs 18.4% to RMB1.08 billion; revenue grows 15.2% to RMB3.42 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2622880991","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622880991?lang=en_us&edition=fundamental","pubTime":"2026-03-26 12:01","pubTimestamp":1774497693,"startTime":"0","endTime":"0","summary":"Consun Pharmaceutical FY2025 profit attributable to equity shareholders climbs 18.4% to RMB1.08 billion; revenue grows 15.2% to RMB3.42 billion. Consun Pharmaceutical published an annual results announcement reporting revenue of RMB3.42 billion, up 15.2%.Profit attributable to equity shareholders was RMB1.08 billion, up 18.4%.Basic earnings per share were RMB1.27, up 14.4%.The board proposed a final dividend of HKD0.40 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Consun Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 26, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL36yyc7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1606","01681","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622984880","title":"Consun Pharmaceutical Group Ltd - Final Dividend of HKD0.40 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2622984880","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622984880?lang=en_us&edition=fundamental","pubTime":"2026-03-26 12:00","pubTimestamp":1774497624,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nPLX28844B:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","01681","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622880987","title":"Consun Pharmaceutical - Profit Attributable for Year RMB1.08 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2622880987","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622880987?lang=en_us&edition=fundamental","pubTime":"2026-03-26 12:00","pubTimestamp":1774497624,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nPLX28844B:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01681","BK1191","BK1606"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chinaconsun.com","stockEarnings":[{"period":"1week","weight":-0.047},{"period":"1month","weight":-0.1},{"period":"3month","weight":-0.2562},{"period":"6month","weight":0.0337},{"period":"1year","weight":0.5541},{"period":"ytd","weight":-0.0793}],"compareEarnings":[{"period":"1week","weight":-0.0279},{"period":"1month","weight":-0.0269},{"period":"3month","weight":-0.0395},{"period":"6month","weight":0.0171},{"period":"1year","weight":0.0832},{"period":"ytd","weight":0.0008}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Consun Pharmaceutical Group Ltd is a company principally engaged in manufacturing and sales of pharmaceutical products. The Company operates its businesses through two segments. Consun Pharmaceutical segment is mainly engaged in manufacturing and sells of modern Chinese medicines and medical contrast medium. Yulin Pharmaceutical segment is mainly involved in manufacturing and sells of traditional Chinese medicines. The Company's products include kidney medicines, gynaecology and paediatrics medicines, contrast medium, orthopedics medicines, dermatologic medicines, hepatobiliary medicines and others. The Company mainly operates its businesses in the domestic market.","yearOnYearQuotes":[{"month":1,"riseRate":0.615385,"avgChangeRate":0.045412},{"month":2,"riseRate":0.538462,"avgChangeRate":0.016845},{"month":3,"riseRate":0.461538,"avgChangeRate":0.017217},{"month":4,"riseRate":0.692308,"avgChangeRate":0.059396},{"month":5,"riseRate":0.538462,"avgChangeRate":0.024085},{"month":6,"riseRate":0.416667,"avgChangeRate":0.002936},{"month":7,"riseRate":0.5,"avgChangeRate":-0.010529},{"month":8,"riseRate":0.583333,"avgChangeRate":0.012771},{"month":9,"riseRate":0.583333,"avgChangeRate":0.028269},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.025864},{"month":11,"riseRate":0.5,"avgChangeRate":0.008603},{"month":12,"riseRate":0.583333,"avgChangeRate":0.021467}],"exchange":"SEHK","name":"CONSUN PHARMA","nameEN":"CONSUN PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CONSUN PHARMA(01681),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CONSUN PHARMA(01681) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CONSUN PHARMA,01681,CONSUN PHARMA股票,CONSUN PHARMA股票老虎,CONSUN PHARMA股票老虎国际,CONSUN PHARMA行情,CONSUN PHARMA股票行情,CONSUN PHARMA股价,CONSUN PHARMA股市,CONSUN PHARMA股票价格,CONSUN PHARMA股票交易,CONSUN PHARMA股票购买,CONSUN PHARMA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CONSUN PHARMA(01681),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CONSUN PHARMA(01681) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}